PL442387A1 - Nowe szczepy bakteriofagów specyficzne wobec bakterii z gatunku Klebsiella pneumoniae i ich zastosowanie do wytwarzania preparatów zwalczających infekcje bakteryjne - Google Patents

Nowe szczepy bakteriofagów specyficzne wobec bakterii z gatunku Klebsiella pneumoniae i ich zastosowanie do wytwarzania preparatów zwalczających infekcje bakteryjne

Info

Publication number
PL442387A1
PL442387A1 PL442387A PL44238722A PL442387A1 PL 442387 A1 PL442387 A1 PL 442387A1 PL 442387 A PL442387 A PL 442387A PL 44238722 A PL44238722 A PL 44238722A PL 442387 A1 PL442387 A1 PL 442387A1
Authority
PL
Poland
Prior art keywords
bacteria
klebsiella pneumoniae
production
bacterial infections
against bacterial
Prior art date
Application number
PL442387A
Other languages
English (en)
Other versions
PL245810B1 (pl
Inventor
Leszek Potocki
Mariusz Worek
Bernadetta Oklejewicz
Aleksandra Baran
Krzysztof Pawlik
Dariusz Martynowski
Norbert Łodej
Dorota Kujawa
Original Assignee
Uniwersytet Rzeszowski
Podkarpackie Centrum Innowacji Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Rzeszowski, Podkarpackie Centrum Innowacji Spółka Z Ograniczoną Odpowiedzialnością filed Critical Uniwersytet Rzeszowski
Priority to PL442387A priority Critical patent/PL245810B1/pl
Publication of PL442387A1 publication Critical patent/PL442387A1/pl
Publication of PL245810B1 publication Critical patent/PL245810B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/00032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Przedmiotem zgłoszenia jest nowy szczep bakteriofaga specyficzny wobec bakterii z gatunku Klebsiella pneumoniae wybrany ze szczepów zdeponowanych w Polskiej Kolekcji Mikroorganizmów pod numerami depozytowymi F/00192; F/00193; F/00194; F/00195, z których każdy ma potwierdzoną naturę lityczną i charakteryzuje się wysoką wirulencją. Zgłoszenie dotyczy także zastosowania szczepu bakteriofaga do wytwarzania preparatów do leczenia infekcji wywołanych przez bakterie z gatunku Klebsiella pneumoniae.
PL442387A 2022-09-28 2022-09-28 Nowe szczepy bakteriofagów specyficzne wobec bakterii z gatunku Klebsiella pneumoniae do zastosowania w zwalczaniu infekcji bakteryjnych PL245810B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL442387A PL245810B1 (pl) 2022-09-28 2022-09-28 Nowe szczepy bakteriofagów specyficzne wobec bakterii z gatunku Klebsiella pneumoniae do zastosowania w zwalczaniu infekcji bakteryjnych

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL442387A PL245810B1 (pl) 2022-09-28 2022-09-28 Nowe szczepy bakteriofagów specyficzne wobec bakterii z gatunku Klebsiella pneumoniae do zastosowania w zwalczaniu infekcji bakteryjnych

Publications (2)

Publication Number Publication Date
PL442387A1 true PL442387A1 (pl) 2024-04-02
PL245810B1 PL245810B1 (pl) 2024-10-14

Family

ID=90526621

Family Applications (1)

Application Number Title Priority Date Filing Date
PL442387A PL245810B1 (pl) 2022-09-28 2022-09-28 Nowe szczepy bakteriofagów specyficzne wobec bakterii z gatunku Klebsiella pneumoniae do zastosowania w zwalczaniu infekcji bakteryjnych

Country Status (1)

Country Link
PL (1) PL245810B1 (pl)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021163663A2 (en) * 2020-02-14 2021-08-19 William Colton Bacteriophage cocktail-containing hydrogel compositions and methods of production and use thereof
CN113583973A (zh) * 2021-08-05 2021-11-02 瑞科盟(青岛)生物工程有限公司 一株高裂解性肺炎克雷伯菌噬菌体rdp-kp-20007及其应用

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021163663A2 (en) * 2020-02-14 2021-08-19 William Colton Bacteriophage cocktail-containing hydrogel compositions and methods of production and use thereof
CN113583973A (zh) * 2021-08-05 2021-11-02 瑞科盟(青岛)生物工程有限公司 一株高裂解性肺炎克雷伯菌噬菌体rdp-kp-20007及其应用

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BAI J, ZHANG F, LIANG S, CHEN Q, WANG W, WANG Y, MART´IN-RODR´IGUEZ AJ, SJÖLING Å, HU R AND ZHOU Y: "Front. Cell. Infect. Microbiol. 12:897531.", ISOLATION AND CHARACTERIZATION OF VB_KPNM_ 17-11, A NOVEL PHAGE EFFICIENT AGAINST CARBAPENEM-RESISTANT KLEBSIELLA PNEUMONIAE, DOI: 10.3389/fcimb.2022.897531 *
BALCÃO, V.M.; MORELI, F.C.; SILVA, E.C.; BELLINE, B.G.; MARTINS, L.F.; ROSSI, F.P.N.; PEREIRA, C.; VILA, M.M.D.C.; DA SILVA, A.M.: "Pharmaceutics 06.07.2022, 14, 1421.", ISOLATION AND MOLECULAR CHARACTERIZATION OF A NOVEL LYTIC BACTERIOPHAGE THAT INACTIVATES MDR KLEBSIELLA PNEUMONIAE STRAINS., DOI: https://doi.org/ 10.3390/pharmaceutics14071421 *

Also Published As

Publication number Publication date
PL245810B1 (pl) 2024-10-14

Similar Documents

Publication Publication Date Title
Cao et al. Acinetobacter lwoffii, an emerging pathogen for fish in Schizothorax genus in China
Spencer On the use of antibiotics for isolating bacteria-free cultures of marine phytoplankton organisms
WO2017067089A1 (zh) 一株水貂肺炎克雷伯氏菌
Tangestani et al. Isolation and characterization of bacteria from the lesion of juvenile sea cucumber Holothuria scabra (Jaeger, 1938) with symptom of skin ulceration disease
US8440446B2 (en) Bacteriophage strains for the treatment of bacterial infections, especially drug resistant strains of the genus Enterococcus
Ohenhen et al. Effects of pH and storage temperatures on antibacterial activity of bacteriocin produced by lactic acid bacteria isolated from ogi.
Pardesh Molecular characterization of Avibacterium paragallinarum isolated from poultry flocks of India
Gagnon et al. Insights into the prevalence of Pseudomonadota and yeasts on milking system surface biofilms
CN110684741B (zh) 一种弧菌噬菌体及其应用
CN103525721A (zh) 具有抑菌能力的益生菌及其应用
Sharma et al. Pathogenicity test of bacterial and fungal fish pathogens in Cirrihinus mrigala infected with EUS disease
Omololu Aso et al. Antibiotic susceptibility pattern of Escherichia coli isolated from out-patient individuals attending the university college hospital (UCH), Ibadan, Nigeria
Steindl et al. Antimicrobial effect of copper on multidrug-resistant bacteria
Kim et al. Fatal Prototheca zopfii Algaemia in a Patient with Acute Lymphoblastic Leukemia: a Case Report.
OCK Bacteraemia among patients attending a cancer hospital in Lahore, Pakistan
Singh et al. Nocardiopsis sp. 5 Endophytic to Tulsi Leaves–Isolation and Antimicrobial Activity
PL430168A1 (pl) Szczepy bakteriofagów specyficzne wobec bakterii należących do rodzaju Salmonella oraz ich zastosowanie do wytwarzania preparatów zwalczających bakterie patogenne
CN111304131A (zh) 强致病力的美人鱼发光杆菌美人鱼亚种菌株及应用
RU2008102619A (ru) ИММУНОБИОЛОГИЧЕСКОЕ ПРОТИВОАЛЛЕРГИЧЕСКОЕ СРЕДСТВО (ВАРИАНТЫ) И ШТАММ Lactobacillus acidophilus 100 аш ПА
PL430175A1 (pl) Szczepy bakteriofagów specyficzne wobec bakterii Escherichia coli oraz ich zastosowanie do wytwarzania preparatów zwalczających bakterie patogenne
PL435199A1 (pl) Kompozycja bakteriofagów specyficzna wobec bakterii z rodziny Enterobacterlaceae, zwłaszcza Escherichia coli, zastosowanie kompozycji bakteriofagów do leczenia zakażeń wywołanych przez bakterie z rodziny Enterobacterlaceae, zwłaszcza Escherichia coli oraz zastosowanie kompozycji bakteriofagów jako czynnika biokontroli
Wainwright Besredka's “antivirus” in relation to Fleming's initial views on the nature of penicillin
Sharaf et al. Isolation, Identification and Antimicrobial Activity of Some Local
Alajekwu et al. Effect of bacteriocin-like inhibitory substances produced by vaginal lactobacilli on group B streptococcus
PL412829A1 (pl) Nowe szczepy bakteriofagów specyficzne wobec bakterii należących do rodzaju Staphylococcus i ich zastosowanie do wytwarzania preparatów zwalczających infekcje bakteryjne